Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2013

Open Access 01-12-2013 | Research

Psychological investigation in patients with polycystic ovary syndrome

Authors: Fatemeh Bazarganipour, Saeide Ziaei, Ali Montazeri, Fatemeh Foroozanfard, Anoshirvan Kazemnejad, Soghrat Faghihzadeh

Published in: Health and Quality of Life Outcomes | Issue 1/2013

Login to get access

Abstract

Background

The aim of the present study was to estimate the prevalence of mood disorders and examine a range of predictors for psychological well-being among Iranian women with polycystic ovary syndrome (PCOS).

Methods

A cross-sectional study was undertaken to ascertain the factors related to psychological distress in PCOS patients in Kashan, Iran. Psychological distress was measured using the Hospital Anxiety and Depression Scale (HADS). In addition we assessed quality of life using the Short Form Health Survey (SF-36). Socio-demographic details and clinical information of PCOS including obesity (body mass index), excessive body hair (hirsutism score), acne, menstrual cycle disturbances, infertility and endocrine profile also were recorded for each patient.

Results

In all 300 women with PCOS were entered into the study. Of these 32% (n =96) showed elevated HADS anxiety while depression was high in 5% (n =15). Quality of life was significantly impaired in women with anxiety (P <0.05), and depression (P <0.001) and in particular, in women with coexistence anxiety and depression (P <0.001) compared with unaffected participants. Compared with the non-depressed PCOS patients, the depressed women had significantly higher menstrual irregularities (P = 0.008). Moreover, we found significant difference in FAI level between the depressed and non depressed (p = 0.05), the anxious and non anxious patients (p < 0.001) compare to non affected PCOS women.

Conclusions

The high prevalence of depression and anxiety in this population suggests that initial evaluation of all women with PCOS should also include assessment of mental health disorders. The clinician should further pay attention to background of their patients especially in view of the factors influencing psychological well-being.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Chedlowski M, et al.: Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Euro J Endocrinol 2005, 153: 853–860. 10.1530/eje.1.02024CrossRef Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Chedlowski M, et al.: Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Euro J Endocrinol 2005, 153: 853–860. 10.1530/eje.1.02024CrossRef
3.
go back to reference Bhattacharya SM, Jha A: Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS). Fertil Steril 2010, 94: 357–359. 10.1016/j.fertnstert.2009.09.025PubMedCrossRef Bhattacharya SM, Jha A: Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS). Fertil Steril 2010, 94: 357–359. 10.1016/j.fertnstert.2009.09.025PubMedCrossRef
4.
go back to reference Laggari V, Diareme S, Christogiorgos S, Deligeoroglou E, Christopoulos P, Tsiantis J, et al.: Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome. J Psychosom Obstet Gynaecol 2009, 30: 83–88. 10.1080/01674820802546204PubMedCrossRef Laggari V, Diareme S, Christogiorgos S, Deligeoroglou E, Christopoulos P, Tsiantis J, et al.: Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome. J Psychosom Obstet Gynaecol 2009, 30: 83–88. 10.1080/01674820802546204PubMedCrossRef
5.
go back to reference Deeks A, Gibson-Helm M, Teede H: Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 2010, 93: 2421–2423. 10.1016/j.fertnstert.2009.09.018PubMedCrossRef Deeks A, Gibson-Helm M, Teede H: Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 2010, 93: 2421–2423. 10.1016/j.fertnstert.2009.09.018PubMedCrossRef
6.
go back to reference Benson S, Arck P, Tan S, Hahn S, Mann K, Rifaie N, et al.: Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology 2009, 34: 727–735. 10.1016/j.psyneuen.2008.12.001PubMedCrossRef Benson S, Arck P, Tan S, Hahn S, Mann K, Rifaie N, et al.: Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology 2009, 34: 727–735. 10.1016/j.psyneuen.2008.12.001PubMedCrossRef
7.
go back to reference Mansson M, Holte J, Landin-Wilhemsen K, Dahlgren E, Johansson A, Landen M: Women with polycystic ovary syndrome are often depressed or anxious: A case control study. Psychoneuroendocrinology 2008, 33: 1132–1138. 10.1016/j.psyneuen.2008.06.003PubMedCrossRef Mansson M, Holte J, Landin-Wilhemsen K, Dahlgren E, Johansson A, Landen M: Women with polycystic ovary syndrome are often depressed or anxious: A case control study. Psychoneuroendocrinology 2008, 33: 1132–1138. 10.1016/j.psyneuen.2008.06.003PubMedCrossRef
8.
go back to reference Eggers S, Kirchengast S: The polycystic ovary syndrome-a medical condition but also an important psychosocial problem. Coll Anthropol 2001, 25: 673–685. Eggers S, Kirchengast S: The polycystic ovary syndrome-a medical condition but also an important psychosocial problem. Coll Anthropol 2001, 25: 673–685.
9.
go back to reference Bishop SC, Basch S, Futterweit W: Polycystic ovary syndrome, depression, and affective disorders. Endocr Pract 2009, 15: 475–482. 10.4158/EP09083.RARPubMedCrossRef Bishop SC, Basch S, Futterweit W: Polycystic ovary syndrome, depression, and affective disorders. Endocr Pract 2009, 15: 475–482. 10.4158/EP09083.RARPubMedCrossRef
10.
go back to reference Benson SHS, Tan S, Mann K, Janssen OE, Schedlowski M, Elsenbruch S: Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reproduction 2009, 24: 1446–1451. 10.1093/humrep/dep031CrossRef Benson SHS, Tan S, Mann K, Janssen OE, Schedlowski M, Elsenbruch S: Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reproduction 2009, 24: 1446–1451. 10.1093/humrep/dep031CrossRef
11.
go back to reference Kerchner A, Lester W, Stuart SP, Dokras A: Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009, 91: 207–212. 10.1016/j.fertnstert.2007.11.022PubMedCrossRef Kerchner A, Lester W, Stuart SP, Dokras A: Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009, 91: 207–212. 10.1016/j.fertnstert.2007.11.022PubMedCrossRef
12.
go back to reference ESHRE/ASRM: ESHRE/ASRM Rotterdam Consensus Meeting Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19: 41–47.CrossRef ESHRE/ASRM: ESHRE/ASRM Rotterdam Consensus Meeting Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19: 41–47.CrossRef
13.
go back to reference Herrmann C: International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997, 42: 17–41. 10.1016/S0022-3999(96)00216-4PubMedCrossRef Herrmann C: International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997, 42: 17–41. 10.1016/S0022-3999(96)00216-4PubMedCrossRef
14.
go back to reference Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S: The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes 2003,28(1):14.CrossRef Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S: The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes 2003,28(1):14.CrossRef
15.
go back to reference Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B: The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 2005,14(3):875–882. 10.1007/s11136-004-1014-5PubMedCrossRef Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B: The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 2005,14(3):875–882. 10.1007/s11136-004-1014-5PubMedCrossRef
16.
go back to reference Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21: 1440–1447. 10.1210/jcem-21-11-1440PubMedCrossRef Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21: 1440–1447. 10.1210/jcem-21-11-1440PubMedCrossRef
17.
go back to reference Lever WF, Schaumburg-Lever G: Acne vulgaris. Histopatbology of the Skin. 7th edn Philadelphia. JB Lippincott 1990, 218: 9. Lever WF, Schaumburg-Lever G: Acne vulgaris. Histopatbology of the Skin. 7th edn Philadelphia. JB Lippincott 1990, 218: 9.
18.
go back to reference Donyavi T, Naieni KH, Nedjat S, Vahdaninia M, Najafi M, Montazeri A: Socioeconomic status and mortality after acute myocardial infarction: a study from Iran. Int J Equity Health 2011,10(1):9. 10.1186/1475-9276-10-9PubMedCentralPubMedCrossRef Donyavi T, Naieni KH, Nedjat S, Vahdaninia M, Najafi M, Montazeri A: Socioeconomic status and mortality after acute myocardial infarction: a study from Iran. Int J Equity Health 2011,10(1):9. 10.1186/1475-9276-10-9PubMedCentralPubMedCrossRef
19.
go back to reference Vankrieken L: Testosterone and the free androgen index. ZB158 edition. Los Angeles: Diagnostics Products; 1997. Vankrieken L: Testosterone and the free androgen index. ZB158 edition. Los Angeles: Diagnostics Products; 1997.
20.
go back to reference Belzer K, Schneier FR: Comorbidity of anxiety and depressive disorders:issues in conceptualization, assessment, and treatment. J Psychiatr Pract 2004, 10: 296–306. 10.1097/00131746-200409000-00003PubMedCrossRef Belzer K, Schneier FR: Comorbidity of anxiety and depressive disorders:issues in conceptualization, assessment, and treatment. J Psychiatr Pract 2004, 10: 296–306. 10.1097/00131746-200409000-00003PubMedCrossRef
21.
go back to reference Stein MB: An epidemiologic perspective on social anxiety disorder. J Clin Psychiatry 2006,67(suppl. 12):3–8.PubMed Stein MB: An epidemiologic perspective on social anxiety disorder. J Clin Psychiatry 2006,67(suppl. 12):3–8.PubMed
22.
go back to reference Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, et al.: Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 2003, 74: 299–304. 10.1016/S0165-0327(02)00117-9PubMedCrossRef Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, et al.: Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 2003, 74: 299–304. 10.1016/S0165-0327(02)00117-9PubMedCrossRef
23.
go back to reference Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L: Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007,22(8):2279–2286. 10.1093/humrep/dem108PubMedCrossRef Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L: Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007,22(8):2279–2286. 10.1093/humrep/dem108PubMedCrossRef
24.
go back to reference Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A: Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007, 87: 1369–1376. 10.1016/j.fertnstert.2006.11.039PubMedCrossRef Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A: Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007, 87: 1369–1376. 10.1016/j.fertnstert.2006.11.039PubMedCrossRef
25.
go back to reference Davidson JR, Meltzer-Brody SE: The under recognition and under treatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry 1999,60(Suppl. 7):4–9.PubMed Davidson JR, Meltzer-Brody SE: The under recognition and under treatment of depression: what is the breadth and depth of the problem? J Clin Psychiatry 1999,60(Suppl. 7):4–9.PubMed
26.
go back to reference Katon W, Von Korff M, Lin E, Lipscomb P, Russo J, Wagner E, et al.: Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990,12(6):355. 10.1016/0163-8343(90)90002-TPubMedCrossRef Katon W, Von Korff M, Lin E, Lipscomb P, Russo J, Wagner E, et al.: Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990,12(6):355. 10.1016/0163-8343(90)90002-TPubMedCrossRef
27.
go back to reference Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML: Depression as an antecedent to heart disease among women and men in the NHANES I study.National Health and Nutrition Examination Survey. Arch Intern Med 2000, 160: 1261–1268. 10.1001/archinte.160.9.1261PubMedCrossRef Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML: Depression as an antecedent to heart disease among women and men in the NHANES I study.National Health and Nutrition Examination Survey. Arch Intern Med 2000, 160: 1261–1268. 10.1001/archinte.160.9.1261PubMedCrossRef
28.
go back to reference Rutledge T, Linke SE, Krantz DS, Johnson BD, Bittner V, Eastwood J, et al.: Comorbid depression and anxiety symptoms as predictors of cardiovascular events:results from the NHLBI-sponsored women’s ischemia syndrome evaluation (WISE) study. Psychosom Med 2009, 71: 958–964. 10.1097/PSY.0b013e3181bd6062PubMedCentralPubMedCrossRef Rutledge T, Linke SE, Krantz DS, Johnson BD, Bittner V, Eastwood J, et al.: Comorbid depression and anxiety symptoms as predictors of cardiovascular events:results from the NHLBI-sponsored women’s ischemia syndrome evaluation (WISE) study. Psychosom Med 2009, 71: 958–964. 10.1097/PSY.0b013e3181bd6062PubMedCentralPubMedCrossRef
29.
go back to reference Himelein MJ, Thatcher SS: Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv 2006, 61: 723–732. 10.1097/01.ogx.0000243772.33357.84PubMedCrossRef Himelein MJ, Thatcher SS: Polycystic ovary syndrome and mental health: a review. Obstet Gynecol Surv 2006, 61: 723–732. 10.1097/01.ogx.0000243772.33357.84PubMedCrossRef
30.
go back to reference Janssen OE, Hahn S, Tan S, Benson S, Elsenbruch S: Mood and sexual function in polycystic ovary syndrome. Semin Reprod Med 2008, 26: 45–52. 10.1055/s-2007-992924PubMedCrossRef Janssen OE, Hahn S, Tan S, Benson S, Elsenbruch S: Mood and sexual function in polycystic ovary syndrome. Semin Reprod Med 2008, 26: 45–52. 10.1055/s-2007-992924PubMedCrossRef
31.
go back to reference Trent MAS, Rich M, Gordon CM: Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005, 5: 107–111. 10.1367/A04-130R.1PubMedCrossRef Trent MAS, Rich M, Gordon CM: Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005, 5: 107–111. 10.1367/A04-130R.1PubMedCrossRef
32.
go back to reference Elsenbruch SBS, Hahn S, Tan S, Mann K, Pleger K, Kimmig R, Janssen OE: Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod 2006, 21: 1092–1099.PubMedCrossRef Elsenbruch SBS, Hahn S, Tan S, Mann K, Pleger K, Kimmig R, Janssen OE: Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod 2006, 21: 1092–1099.PubMedCrossRef
33.
go back to reference Adali E, Yildizhan R, Kurdoglu M, Kolusari A, Edirne T, Sahin HG, et al.: The relationship between clinico-biochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome. J Int Med Res 2008,36(6):1188–1196. 10.1177/147323000803600604PubMedCrossRef Adali E, Yildizhan R, Kurdoglu M, Kolusari A, Edirne T, Sahin HG, et al.: The relationship between clinico-biochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome. J Int Med Res 2008,36(6):1188–1196. 10.1177/147323000803600604PubMedCrossRef
34.
go back to reference De Niet JE, De Koning CM, Pastoor H, Duivenvoorden HJ, Valkenburg O, Ramakers MJ, et al.: Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod 2010,25(6):1497–1503. 10.1093/humrep/deq068PubMedCrossRef De Niet JE, De Koning CM, Pastoor H, Duivenvoorden HJ, Valkenburg O, Ramakers MJ, et al.: Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod 2010,25(6):1497–1503. 10.1093/humrep/deq068PubMedCrossRef
35.
go back to reference Kitzinger C, Willmott J: The thief of womanhood’: women’s experience of polycystic ovarian syndrome. Soc Sci Med 2002, 54: 349–361. 10.1016/S0277-9536(01)00034-XPubMedCrossRef Kitzinger C, Willmott J: The thief of womanhood’: women’s experience of polycystic ovarian syndrome. Soc Sci Med 2002, 54: 349–361. 10.1016/S0277-9536(01)00034-XPubMedCrossRef
36.
go back to reference Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Faghihzadeh S: Health-related quality of life and its relationship with clinical symptoms among Iranian patients with polycystic ovarian syndrome. Iran J Reprod Med 2013,11(5):371–378.PubMedCentralPubMed Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Faghihzadeh S: Health-related quality of life and its relationship with clinical symptoms among Iranian patients with polycystic ovarian syndrome. Iran J Reprod Med 2013,11(5):371–378.PubMedCentralPubMed
37.
go back to reference Omran AR: Family Planning in the Legacy of Islam. London: Routledge; 1992. Omran AR: Family Planning in the Legacy of Islam. London: Routledge; 1992.
38.
go back to reference Barry JA, Bouloux P, Hardiman PJ: The impact of eating behavior on psychological symptoms typical of reactive hypoglycemia. A pilot study comparing women with polycystic ovary syndrome to controls. Appetite 2011,57(1):73–6. 10.1016/j.appet.2011.03.003PubMedCrossRef Barry JA, Bouloux P, Hardiman PJ: The impact of eating behavior on psychological symptoms typical of reactive hypoglycemia. A pilot study comparing women with polycystic ovary syndrome to controls. Appetite 2011,57(1):73–6. 10.1016/j.appet.2011.03.003PubMedCrossRef
39.
go back to reference Livadas S, Chaskou S, Kandaraki AA, Skourletos G, Economou F, Christou M, et al.: Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol 2011,75(5):698–703. 10.1111/j.1365-2265.2011.04122.xCrossRef Livadas S, Chaskou S, Kandaraki AA, Skourletos G, Economou F, Christou M, et al.: Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. Clin Endocrinol 2011,75(5):698–703. 10.1111/j.1365-2265.2011.04122.xCrossRef
40.
go back to reference Farrell K, Antoni MH: Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril 2010,94(5):1565–74. 10.1016/j.fertnstert.2010.03.081PubMedCentralPubMedCrossRef Farrell K, Antoni MH: Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril 2010,94(5):1565–74. 10.1016/j.fertnstert.2010.03.081PubMedCentralPubMedCrossRef
Metadata
Title
Psychological investigation in patients with polycystic ovary syndrome
Authors
Fatemeh Bazarganipour
Saeide Ziaei
Ali Montazeri
Fatemeh Foroozanfard
Anoshirvan Kazemnejad
Soghrat Faghihzadeh
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2013
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-11-141

Other articles of this Issue 1/2013

Health and Quality of Life Outcomes 1/2013 Go to the issue